Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Spectrum Pharmaceuticals says FDA doesn't approve Fusilev for colon cancer, recommends meeting
Spectrum Pharmaceuticals says FDA doesn't approve Fusilev for colon cancer, recommends meeting
Spectrum Pharmaceuticals says FDA doesn't approve Fusilev for colon cancer, recommends meeting
Submitted by
admin
on October 9, 2009 - 9:58am
Source:
Yahoo/AP
News Tags:
Fusilev
FDA
colon cancer
Spectrum Pharmaceuticals
Headline:
Spectrum Pharmaceuticals says FDA doesn't approve Fusilev for colon cancer, recommends meeting
Do Not Allow Advertisers to Use My Personal information
